• About Us
  • News
  • For Medical Professionals
Home › Treatment
  • About Cutaneous Lymphoma
  • Treatment
  • Programs & Resources
  • Research
  • Advocacy
  • Ways to Give
  • Get Involved
  • Donate

Treatment

Treatment

  • Treatment Options
    • Skin Directed Therapies
    • Systemic Therapies
      • Oral Corticosteroids
      • Bexarotene (Targretin®) Capsules
      • Photopheresis
      • Interferons
      • Denileukin Diftitox (Ontak®)
      • Alemtuzumab (Campath®)
      • Vorinostat (Zolinza®)
      • Romidespin (Istodax®)
      • Methotrexate (Matrex®)
      • Pentostatin (Nipent®, Deoxycoformycin)
      • Liposomal Doxorubicin (Doxil®)
      • Gemcitabine (Gemzar®)
      • Cyclophosphamide-Oral (Cytoxan®)
      • Multi-Agent Chemotherapy
      • Bone marrow/Stem cell Transplantation
  • Treatment Centers
  • Compounding Pharmacies
  • Your Healthcare Team

Systemic Therapies

Targeted/ Biological / Immuno- therapies:
Oral Corticosteroids
Bexarotene (Targretin®) Capsules
Photopheresis
Interferons
Denileukin Diftitox (Ontak®)
Alemtuzumab (Campath®)

HDAC inhibitors:
Vorinostat (Zolinza®)
Romidepsin (Istodax®)

Chemotherapies (Single & Multi-Agent)
Methotrexate
Pentostatin & other purine,  analogues (Fludarabine, 2- deoxychloroadenosine)
Liposomal doxorubicin (Doxil®)
Gemcitabine (Gemzar®)
Cyclophosphamide, oral

Combination chemotherapy (CHOP regimen)

Bone marrow / Stem cell transplantation:
Bone marrow/Stem cell Allogeneic Transplantation

Home | Disclaimer | Copyright Notice | Contact Us

Cutaneous Lymphoma Foundation • PO Box 374, Birmingham, MI 48012 • (248) 644-9014 • info@clfoundation.org • www.clfoundation.org